Literature DB >> 3518441

Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature.

R L Wong, J H Korn.   

Abstract

An elevated erythrocyte sedimentation rate is regarded as a hallmark of temporal arteritis. Thirty-five cases of biopsy-proved temporal arteritis without an elevated erythrocyte sedimentation rate are identified, and a 36th case is described. All patients had age-adjusted normal Westergren sedimentation rates, 16 with sedimentation rates of 20 mm per hour or less and 20 with sedimentation rates of 21 to 40 mm per hour. Twenty-two patients had sufficient clinical information for analysis and comparison with reported series of patients with biopsy-proved temporal arteritis with an elevated Westergren sedimentation rate. Headache (41 percent), temporal artery abnormalities (41 percent), and visual symptoms (36 percent) were the most common manifestations in patients without an elevated sedimentation rate. Headache (41 percent versus 75 percent, p less than 0.05) and jaw claudication (9 percent versus 43 percent, p less than 0.025) were found less often in the patients without an elevated sedimentation rate. History and physical examination are essential in the diagnosis of temporal arteritis with a normal Westergren sedimentation rate.

Entities:  

Mesh:

Year:  1986        PMID: 3518441     DOI: 10.1016/0002-9343(86)90645-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

Review 1.  Giant cell arteritis.

Authors:  Todd J Schwedt; David W Dodick; Richard J Caselli
Journal:  Curr Pain Headache Rep       Date:  2006-12

2.  Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis?

Authors:  G P Brittain; G G McIlwaine; J A Bell; J M Gibson
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

3.  Giant cell arteritis with normal ESR and/or CRP is rare, but not unique!

Authors:  A Grzybowski; A Justynska
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

4.  Response to Grzybowski and Justynska.

Authors:  S L Levy; A D Bull; A R Nestel
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

5.  Giant cell arteritis presenting as pulseless disease of the upper extremities.

Authors:  G S Hatzis; K G Aroni; D A Kelekis; K A Boki
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 6.  Giant cell arteritis: difficult decisions in diagnosis, investigation and treatment.

Authors:  E W Paice
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

7.  CRP in the management of polymyalgia rheumatica and giant cell arteritis.

Authors:  S Schreiber
Journal:  Clin Rheumatol       Date:  1987-03       Impact factor: 2.980

Review 8.  Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein.

Authors:  A Laria; A Zoli; M Bocci; F Castri; F Federico; G F Ferraccioli
Journal:  Clin Rheumatol       Date:  2012-07-22       Impact factor: 2.980

9.  Headache Caused by Giant Cell Arteritis.

Authors:  Thomas N Ward; Morris Levin; Robert L Wong
Journal:  Curr Treat Options Neurol       Date:  2004-11       Impact factor: 3.598

10.  Polymyalgia rheumatica, temporal arteritis and malignancy.

Authors:  C A Speed; I Haslock
Journal:  Postgrad Med J       Date:  1995-08       Impact factor: 2.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.